ucsf banner
Left Navigation Pane Image
Department of Clinical Pharmacy

Volunteer Faculty & Staff

M
McNicholl, Ian R., Pharm.D., BCPS (AQ-Infectious Diseases), AAHIVE McNicholl, Ian R., Pharm.D., BCPS (AQ-Infectious Diseases), AAHIVE

  • Current Title(s):
    • Associate Clinical Professor
    • Clinical Pharmacy Specialist, Positive Health Program/Department of Medicine
    • Editor, UCSF Center for HIV Information, Database of Antiretroviral Drug Interactions
  • Education:
    • University of California, Berkeley, B.A. Biology, 1984-1989
    • University of California, San Francisco, Pharm.D., 1989-1993
  • Licensure:
    • Illinois Department of Professional Regulation
    • California Board of Pharmacy
    • Board Certified Pharmacotherapy Specialist (BCPS), 1998
    • Added Qualifications in Infectious Diseases Pharmacotherapy, 2000
    • American Academy of HIV Medicine HIV Subject Matter Expert (AAHIVE), 2009
  • Specialty:
    • HIV
    • Infectious Diseases
    • Primary Care
  • Special Appointments/Fellowships/Awards:
    • Invited Panel Member, Department of Health and Human Services / Infectious Disease Society of America, Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Persons

San Francisco General Hospital, UCSF Positive Health Program/Department of Medicine  995 Potrero Ave., Bldg 80, Ward 86, San Francisco, CA 94110
Phone: (415) 206-2421,  Fax: (415) 502-9568,  Email: imcnicholl@php.ucsf.edu


Professional Biography
Dr. McNicholl is a Clinical Pharmacy Specialist with the Department of Medicine/UCSF Positive Health Practice and an Associate Clinical Professor with the UCSF School of Pharmacy. Board certified in Pharmacotherapy with Added Qualifications in Infectious Diseases, Dr. McNicholl has held faculty appointments with the University of Illinois-Chicago, University of Colorado and the St. Louis College of Pharmacy.

Over the last 10+ years in Infectious Disease, he has had a clinical practice at University of Illinois, Kaiser Permanente, St. Louis Veterans Affairs Medical Center and the Barnes-Jewish Hospital and Clinics.

His primary focus is maintaining a clinical practice at the UCSF Positive Health Practice at San Francisco General Hospital where the clinic provides comprehensive healthcare for approximately 3,000 HIV positive patients. Other major responsibilities include managing a pharmacist staffed Adherence Support Program and serving as Editor, UCSF Center for HIV Information, Database of Antiretroviral Drug Interactions. He has published and presented on lectures, Continuing Education programs and research findings on Infectious Diseases and Primary Care issues from the local level on up.


Selected Peer-reviewed Publications

  • Jagannathan P, McElfresh A, McNicholl IR, Hare CB. Pharmacist–managed adherence support and its impact on viral load suppression and CD4 count [abstract WEAB0305]. XVII International AIDS Conference, Mexico City, Mexico. 3-8 August, 2008.
  • Cohan D, Feakins C, Wara D, Petru A, McNicholl I, Schillinger D, et al. Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen. AIDS 2005; 19: 989-94.
  • McNicholl IR, Parrish VA. Effectiveness and Tolerability of Atazanavir in an Urban, Indigent, Co-infected Population [poster 119]. American College of Clinical Pharmacy Annual Meeting. St. Louis, Missouri. October 26-29, 2006.
  • McNicholl IR, Vogel M, Coffey S, Mandel N, Peiperl L. ARV alert: an innovative resource for timely information about important antiretroviral interactions and adverse effects. International AIDS Society USA 7th Annual Conference for Ryan White Care Act Title I, II, III and IV Grantees, Washington, D.C. August 2004.
  • McNicholl IR, McNicholl JJ. On the Horizon: Promising Investigational Antiretroviral Agents. Curr Pharmaceutical Design 2006; 12: 1091-1103.
  • Fulco P, McNicholl IR. Novel Non-Nucleoside Reverse Transcriptase Inhibitors with Activity against HIV-1 Strains Resistant to Previous Non-Nucleosides: Etravirine and Rilpivirine. Pharmacotherapy 2008.
  • McNicholl IR. Strategies to Enhance Adherence, Reduce Costs and Improve Patient Quality of Life. JMCP 2008; 14 (Suppl a): S12-16.
  • McNicholl I, German P, Cohan D, Feakins C and Aweeka F. Crossover, Steady-State Comparison of Lopinavir/ritonavir (LPV/RTV) Pharmacokinetics (PK) in Women of Colour [poster P288]. Presented at the Eighth International Congress on Drug Therapy in HIV Infection; Glasgow, Scotland. November 12-16, 2006.
  • McNicholl IR. An Internet-Based, Searchable Database of Antiretroviral Drug Interactions. National AETC Faculty Development Workshop, San Francisco, California. June 24-26, 2004
  • Aziz N, Feakins C, McNicholl I, Cohan D. Viral Decay in Pregnant Women on Highly Active Antiretroviral Therapy. Presented at the Infectious Diseases Society for Obstetrics and Gynecology, Monterey, California. August 3-5, 2006.
  • McNicholl I, Parrish V. Clinical Effects of the Atazanavir and H2-Blocker Interaction on CD4 Count and Viral Load [poster P284]. Presented at the Eighth International Congress on Drug Therapy in HIV Infection; Glasgow, Scotland. November 12-16, 2006.
  • Jamjian MC, McNicholl IR. Enfuvirtide: first fusion inhibitor for treatment of HIV infection. Am J Health-System Pharmacy 2004;61:1242-7.
  • McNicholl IR. Drug interactions among the antiretrovirals. Current Infectious Disease Reports 2004; 6: 159-62.
  • Ritchie D. McNicholl IR. Opportunistic Infections, Pharmacotherapy Self-Assessment Program (PSAP-IV), American College of Clinical Pharmacy, 2001
  • McNicholl IR, Lusk RH. Utility of the mean possession ratio in assessing antiretroviral adherence. Orally presented at the American College of Clinical Pharmacy Annual Meeting. Los Angeles, California. November 5-8, 2000. [abst#99].
  • Cocohoba JM, McNicholl IR. Valganciclovir, an advance in CMV therapy. Ann Pharmacother 2002;36:1075-9.
  • McNicholl IR, McNicholl JJ. Treatment of HIV infection. U.S. Pharmacist 2002; June (Suppl):1-16.
  • McNicholl IR, Jacobson M. Ganciclovir and Valganciclovir. The Use of Antibiotics, A Clinical Review of Antibacterial, Antifungal And Antiviral Drugs, 6th ed. Kucers A, Crowe SM, Grayson ML, Hoy, JF. eds. Oxford University Press, 2009.
  • McNicholl IR, Lusk RH. Risk factors for non-adherence in an urban, HIV-infected veterans population. Presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada. September 17-20, 2000. [abst #794].
  • McNicholl IR. Antiviral Drugs. Chapter 29. Side Effects of Drugs Annual, 26th ed. (SEDA-26). Aronson, JK, ed. Elsevier. 2003. p. 328-38.
M